Effects of pupil-dilating drug on myopia progression and intraocular pressure elevatio

Not Applicable

Completed

• Conditions: Myopia in children; Eye Diseases; Myopia

• Registration Number: ISRCTN33002849
• Lead Sponsor: Chang Gung Memorial Hospital

Brief Summary

2016 results in https://pubmed.ncbi.nlm.nih.gov/27435576/ (added 30/11/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2011-03-01
• Study Start: 2016-05-31
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

1. Children in Northern Taiwan aged between 6 to 12 years.
2. Patients with a refractive error less than -3.0 diopters (D)

Exclusion Criteria

1. Congenital eye disorder
2. Any disease influence the cornea, lens or retina
3. Best correct visual acuity<20/25 using the Snellen chart
4. Primary intraocular pressure above 21mmHg
5. Atropine application within 6 months before enrollment
6. Patients who could understand the details of this study or could not adhere to the follow up schedule

Study & Design

• Study Type: Interventional
• Study Design: Not specified